Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

161.97
Delayed Data
As of 4:14pm ET
 -4.14 / -2.49%
Today’s Change
71.46
Today|||52-Week Range
167.86
+119.86%
Year-to-Date
Top Stock Picks for the Week of July 24th
4:41pm / Zacks.com - Paid Partner Content
DST Systems (DST) Q2 Earnings: Is a Surprise in Store?
10:02am / Zacks.com - Paid Partner Content
Drug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK
11:51am / Zacks.com - Paid Partner Content
Gigamon (GIMO) to Report Q2 Earnings: What's in the Cards?
10:02am / Zacks.com - Paid Partner Content
What's in the Cards for Geron (GERN) this Earnings Season?
11:30am / Zacks.com - Paid Partner Content
Xilinx (XLNX) to Post Q1 Earnings: What's in the Cards?
9:29am / Zacks.com - Paid Partner Content
Can Intercept (ICPT) Beat Estimates this Earnings Season?
11:19am / Zacks.com - Paid Partner Content
Why Vertex Pharmaceuticals (VRTX) Might Surprise This Earnings Season
9:19am / Zacks.com - Paid Partner Content
Will Radius Health (RDUS) Disappoint this Earnings Season?
10:18am / Zacks.com - Paid Partner Content
What's in the Cards for Exelixis (EXEL) in Q2 Earnings?
Jul 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close166.11
Today’s open166.94
Day’s range161.72 - 167.86
Volume2,421,490
Average volume (3 months)2,153,675
Market cap$41.4B
Dividend yield--
Data as of 4:14pm ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)+80.09%
Earnings growth (this year)+93.27%
Earnings growth (next 5 years)+68.90%
Revenue growth (last year)+64.89%
P/E ratio231.4
Price/Sales10.59
Price/Book35.66

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.64-1.02%
SHPGShire+2.47+1.51%
ZTSZoetis Inc-2.01-3.18%
ALXNAlexion Pharmaceutic...-1.39-1.06%
Data as of 4:01pm ET, 07/25/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$0.35
Annual revenue (last year)$1.7B
Annual profit (last year)-$112.1M
Net profit margin-6.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
EVP, Chief Operating &
Financial Officer
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts